C the Signs
C the Signs has developed an AI-based platform to identify patients at risk of cancer at its earliest and most curable stage. The platform analyzes data from electronic health records to assess individual cancer risk, recommending targeted testing and reducing unnecessary procedures. This approach has already shown success in the UK's NHS, identifying cancers years earlier than traditional methods.
Funding Round:
Funding Amount: $8M
Date: 31-Jan-2025
Investors: Khosla Ventures
Markets: AI, Healthtech, Hospitals and Health Care, Diagnostic Equipment, Biotechnology, Other Healthcare Technology Systems
HQ: London, England, United Kingdom
Founded: 2017
Website: https://www.cthesigns.com/
LinkedIn: https://www.linkedin.com/company/c-the-signs
Twitter: https://twitter.com/cthesignstool
Crunchbase: https://www.crunchbase.com/organization/c-the-signs
Leave a Comment
Comments
No comments yet.